These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25237065)

  • 1. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.
    Hoste EA; McCullough PA; Kashani K; Chawla LS; Joannidis M; Shaw AD; Feldkamp T; Uettwiller-Geiger DL; McCarthy P; Shi J; Walker MG; Kellum JA;
    Nephrol Dial Transplant; 2014 Nov; 29(11):2054-61. PubMed ID: 25237065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
    Kashani K; Al-Khafaji A; Ardiles T; Artigas A; Bagshaw SM; Bell M; Bihorac A; Birkhahn R; Cely CM; Chawla LS; Davison DL; Feldkamp T; Forni LG; Gong MN; Gunnerson KJ; Haase M; Hackett J; Honore PM; Hoste EA; Joannes-Boyau O; Joannidis M; Kim P; Koyner JL; Laskowitz DT; Lissauer ME; Marx G; McCullough PA; Mullaney S; Ostermann M; Rimmelé T; Shapiro NI; Shaw AD; Shi J; Sprague AM; Vincent JL; Vinsonneau C; Wagner L; Walker MG; Wilkerson RG; Zacharowski K; Kellum JA
    Crit Care; 2013 Feb; 17(1):R25. PubMed ID: 23388612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
    Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
    Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
    J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
    Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
    BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure.
    Schanz M; Shi J; Wasser C; Alscher MD; Kimmel M
    Clin Cardiol; 2017 Jul; 40(7):485-491. PubMed ID: 28295429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.
    Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A
    PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
    Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
    PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
    Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
    Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
    Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
    Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cell cycle arrest biomarkers in patients at high risk for acute kidney injury: A systematic review and meta-analysis.
    Jia HM; Huang LF; Zheng Y; Li WX
    Nephrology (Carlton); 2017 Nov; 22(11):831-837. PubMed ID: 28646585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interest of Urinary [TIMP-2] × [IGFBP-7] for Predicting the Occurrence of Acute Kidney Injury After Cardiac Surgery: A Gray Zone Approach.
    Finge T; Bertran S; Roger C; Candela D; Pereira B; Scott C; Muller L; Louart B; Lefrant JY
    Anesth Analg; 2017 Sep; 125(3):762-769. PubMed ID: 28537976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery.
    Gist KM; Goldstein SL; Wrona J; Alten JA; Basu RK; Cooper DS; Soranno DE; Duplantis J; Altmann C; Gao Z; Faubel S
    Pediatr Nephrol; 2017 Sep; 32(9):1611-1619. PubMed ID: 28382566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.
    Titeca-Beauport D; Daubin D; Van Vong L; Belliard G; Bruel C; Alaya S; Chaoui K; Andrieu M; Rouquette-Vincenti I; Godde F; Pascal M; Diouf M; Vinsonneau C; Klouche K; Maizel J
    Crit Care; 2020 Jun; 24(1):280. PubMed ID: 32487237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery-A Pilot Study.
    Mayer T; Bolliger D; Scholz M; Reuthebuch O; Gregor M; Meier P; Grapow M; Seeberger MD; Fassl J
    J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2072-2079. PubMed ID: 28803769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.
    Gunnerson KJ; Shaw AD; Chawla LS; Bihorac A; Al-Khafaji A; Kashani K; Lissauer M; Shi J; Walker MG; Kellum JA;
    J Trauma Acute Care Surg; 2016 Feb; 80(2):243-9. PubMed ID: 26816218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: A prospective multicentre study.
    Titeca-Beauport D; Daubin D; Chelly J; Zerbib Y; Brault C; Diouf M; Slama M; Vinsonneau C; Klouche K; Maizel J
    Resuscitation; 2019 Aug; 141():104-110. PubMed ID: 31216431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cell cycle arrest proteins urinary tissue inhibitor of metalloprotease 2 and insulin-like growth factor binding protein 7 predict acute kidney injury after severe trauma: A prospective observational study.
    Hatton GE; Wang YW; Isbell KD; Finkel KW; Kao LS; Wade CE
    J Trauma Acute Care Surg; 2020 Oct; 89(4):761-767. PubMed ID: 33009198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.